NeuroRx awarded FDA Fast Track Designation for first drug regimen targeting suicide in bipolar depression

NeuroRX , Acute Suicidal Ideation and Behavior , NRX-100 , NRX-100 , NeuroRx, a clinical stage biopharmacompany developing the first oral therapy for Acute Suicidal Ideation and Behavior (ASIB), has been granted Fast Track status by the US FDA...

mProve Health and Greenphire Partner to Delivera First-of-its-Kind Patient Engagement Solution

mProve Health, a leading provider of mobile technologies announceda partnership to provide patients with real-time access to ClinCard payment detailsvia mProve engagement app, mPal..

License Expansion for RGN-137 in Europe, S. Korea, Japan, Canada and Australia Completed By RegeneRX

RegeneRx Biopharmaceuticals, Inc., announced that it has completed a license expansion agreement with GtreeBNT for the rights to RGN-137, RegeneRx topical gel formulation of thymosin beta 4...

Contract Manufacturing Organizations: Navigating Serialization Implementation

In recent years the pharmaceutical industry has seen a significant change to the way its manufacturersand supply chains operate, due to the establishment of several serialization and track and trace regulations...

Zavante announce agreement to assess ZOLYD for lower respiratory tract infections with NIAID

Zavante Therapeutics, Inc signed a Clinical Trial Agreement with the National Institute of Allergy and Infectious Disease (NIAID) to evaluate Zavante investigational antibiotic ZOLYD...

J and J announces partnership with CSIR-IMTECH to develop innovative new tuberculosis treatments

J and J Pvt Ltd announced a new partnership with the IMTECH , part of the Council of Scientific and Industrial Research (CSIR), to unlock the potential of Indian science and help accelerate the discovery...

For Advertising Queries:

Please e-mail : kathryn@worldpharmatoday.com
or
call to: + 91 88268 49084

If you like to receive our latest Media Pack 2017 / Editorial Calender please click here

For the latest visit: www.worldpharmatoday.com